{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000710","form_type":"8-K","ticker":"FONR","cik":"0000355019","company_name":"FONAR CORP","filed_at":"2026-05-12T21:12:07+00:00","discovered_at":"2026-05-12T21:14:00.439964+00:00","generated_at":"2026-05-12T21:18:11.943720+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"FONAR Q3 net income down 25% to $2.3M; shareholder vote on take-private set for May 28","bullets":["Diluted EPS $0.24, down 35% YoY; revenue $26.5M, down 3% from $27.2M.","Operating income $2.4M, down 33%; SG&A up 5% to $8.4M.","Record Q3 scan volume of 55,660 scans, up 1.5% sequentially; HMCA manages 45 MRI scanners.","Cash and equivalents $53.8M, down 4% from June 30, 2025.","Share repurchases suspended; special meeting to approve go-private merger scheduled for May 28, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000710","json":"https://secwatch.observer/filing/0001731122-26-000710.json","markdown":"https://secwatch.observer/filing/0001731122-26-000710.md","text":"https://secwatch.observer/filing/0001731122-26-000710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/355019/000173112226000710/0001731122-26-000710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/355019/000173112226000710/fonar_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T21:18:11.943720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52b518fc9a966bf9f6b7ea6b36c88ab272c01666","claim":"FONAR CORP reported the quarter ended March 31, 2026 results: revenue $26.5 million, net income $2.3 million, EPS $0.24 per share.","evidence_excerpt":"Stockholders decreased 35% to $0.24 per share for the quarter ended March 31, 2026 as compared to th e quarter ended March 31, 2025. · Total Revenues-Net decreased 3% to $26.5 million for the quarter ended March 31, 2026 as compared to the quarter ended March 31, 2025. · Total Cash, Cash Equivalents and Short-Term Investments decreased 4% to $53.8 million at","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/355019/000173112226000710/0001731122-26-000710-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Revenue","value":"$26.5 million"},{"label":"Net income","value":"$2.3 million"},{"label":"EPS","value":"$0.24 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"afd2333d19f22792e025c4b5a751a926aa13f900","claim":"FONAR CORP reported the nine-month period ended March 31, 2026 results: revenue $78.1 million, net income $7.5 million, EPS $0.89 per share.","evidence_excerpt":"31, 2026 decreased 3% to $26.5 million as compared to $27.2 million for the quarter ended March 31, 2025. Total Revenues-Net for the nine-month period ended March 31, 2026 was $78.1 million as compared to $77.1 million for the nine-month period ended March 31, 2025. Selling, general & administrative costs (SG&A) increased 5% to $8.4 million for the quarter ended","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/355019/000173112226000710/0001731122-26-000710-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the nine-month period ended March 31, 2026"},{"label":"Revenue","value":"$78.1 million"},{"label":"Net income","value":"$7.5 million"},{"label":"EPS","value":"$0.89 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}